Intervention: HX575 solution for s.c. administration
Found 5 matching trials
Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
PHASE3
This is a randomized, controlled, double-blind, multicenter multinational s...
Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)
PHASE3
This is an open-label, single-arm, baseline-controlled, multicenter efficac...